Financial reports
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
10-K
2022 FY
Annual report
13 Mar 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2022 Q1
Quarterly report
28 Apr 22
10-K
2021 FY
Annual report
21 Mar 22
10-Q
2021 Q3
Quarterly report
2 Nov 21
Current reports
8-K
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 24
8-K
Zynex Announces Share Repurchase Program
1 Nov 23
8-K
Zynex Announces Review of Strategic Alternatives
31 Oct 23
8-K
Zynex Reports Third Quarter 2023 Financial Results
26 Oct 23
8-K
Zynex Announces Share Repurchase Program
11 Sep 23
8-K
Entry into a Material Definitive Agreement
28 Jul 23
8-K
Zynex Reports Second Quarter 2023 Financial Results
27 Jul 23
8-K
Zynex Reports Preliminary Second Quarter 2023 Results
12 Jul 23
8-K
Zynex Receives FDA Clearance of CM-1600 Monitor for Improved Blood and Fluid Management
20 Jun 23
8-K
Zynex Announces Share Buyback Program
14 Jun 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
3 May 23
424B5
Prospectus supplement for primary offering
16 Jul 20
424B7
Prospectus with selling stockholder info
16 Jul 20
424B5
Prospectus supplement for primary offering
14 Jul 20
424B7
Prospectus with selling stockholder info
14 Jul 20
424B5
Prospectus supplement for primary offering
29 Oct 19
S-3
Shelf registration
26 Jun 19
S-3
Shelf registration
7 Mar 19
8-A12B
Registration of securities on exchange
7 Feb 19
8-A12G
Registration of securities
9 Jul 18
Proxies
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
DEFA14A
Additional proxy soliciting materials
30 Mar 23
DEF 14A
Definitive proxy
30 Mar 23
DEFA14A
Additional proxy soliciting materials
8 Apr 22
DEF 14A
Definitive proxy
1 Apr 22
DEF 14A
Definitive proxy
2 Apr 21
DEFA14A
Additional proxy soliciting materials
2 Apr 20
DEF 14A
Definitive proxy
2 Apr 20
PRE 14C
Preliminary information
27 Aug 02
Other
EFFECT
Notice of effectiveness
5 Jul 19
UPLOAD
Letter from SEC
2 Jul 19
CORRESP
Correspondence with SEC
1 Jul 19
EFFECT
Notice of effectiveness
13 Mar 19
UPLOAD
Letter from SEC
11 Mar 19
CORRESP
Correspondence with SEC
8 Mar 19
CERT
Certification of approval for exchange listing
11 Feb 19
UPLOAD
Letter from SEC
29 Sep 09
CORRESP
Correspondence with SEC
18 Sep 09
UPLOAD
Letter from SEC
8 Sep 09